Edwards Lifesciences Corp (EW) has experienced notable shifts recently, with varying outlooks on its performance. The company is gaining traction in the markets due to speculation over takeover bids.
Itau Unibanco Holding S.A. has invested
$1.92 Million in the bio-tech company, while
Skandinaviska Enskilda Banken AB publ has holdings worth
$43.68 Million. There are also discussions about its ability to manage its debt, amplified by recent growth opportunities and strong financial prospects. However,
Intech Investment Management LLC and
Amalgamated Bank have cut and sold their stock holdings respectively, raising concerns about its future. Reports suggest that despite a
31% crash after slashing guidance, its Q2 earnings met market expectations even though margins crashed. Some maintain cautious optimism on the company’s outlook; notably, the company’s
Q2 earnings matched estimates but there are concerns related to lower
TAVR growth.
BD's acquisition of Edwards Lifesciences'
Critical Care Product Group for
$4.2 Billion helped bolster its market position. Notably, Edwards Lifesciences also completed the sales of its
Critical Care. Furthermore, it applied
$1.2B on two more M&A deals and is set for a spin-off of the critical-care unit and a stock buyback worth
$1B.
Edwards Lifesciences Corp EW News Analytics from Thu, 07 Dec 2023 08:00:00 GMT to Sun, 22 Sep 2024 11:33:53 GMT -
Rating 4
- Innovation 2
- Information 7
- Rumor -3
